Neurofeedback for ADHD
Backed by nearly 50 years of peer-reviewed research, EEG neurofeedback is one of the longest-studied non-pharmacological interventions for attention and self-regulation.
50 years
of EEG neurofeedback research, since Lubar 1976
Level 1
AAP Best Support rating for biofeedback in ADHD
10+ RCTs
showing meaningful symptom reduction
ADHD has the longest neurofeedback research history of any clinical condition. Joel Lubar and colleagues began publishing controlled studies in 1976, and by the 2000s multiple research groups – Monastra, Levesque, Gevensleben, Arns – had replicated the basic finding that training sensorimotor rhythm and theta/beta ratios produces measurable, sustained improvements in attention, impulsivity, and academic performance.
What the Research Shows
EEG neurofeedback consistently improves core ADHD symptoms across decades of clinical use, with the strongest effects on inattention, processing speed, and self-regulation. Standard protocols (theta/beta, slow cortical potentials, sensorimotor rhythm) produce gains comparable to behavioural therapy and durable beyond the end of treatment – in multiple follow-up studies, benefits actually grow over the months after training stops.
How EEG Neurofeedback Addresses ADHD
People with ADHD often show distinctive EEG patterns – elevated frontal-central theta-to-beta ratios and atypical slow cortical potentials related to anticipation and effort. EEG neurofeedback measures these patterns in real time and rewards the brain when it shifts toward the more focused state. Across multiple sessions, the brain learns to find and hold those states on its own. The most studied protocols are theta/beta training (Lubar), slow cortical potential training (Strehl, Birbaumer, Gevensleben), and sensorimotor rhythm reinforcement.
Foundational Research
The ADHD neurofeedback canon – cited extensively in the ISNR Comprehensive Bibliography – establishes the basic finding across multiple research groups and decades.
Lubar & Shouse, 1976 – first SMR neurofeedback study in a hyperactive child
Biofeedback & Self-Regulation, 1(3): 293-306.
The seminal paper that launched EEG neurofeedback for ADHD. SMR enhancement training produced clear improvements in hyperactivity and attention, with reversal during a contingency-reversal phase confirming the operant-conditioning mechanism. DOI: 10.1007/BF00998997 | PMID 990357
Linden, Habib & Radojevic, 1996 – controlled study of EEG biofeedback in children with ADHD
Biofeedback & Self-Regulation, 21(1): 35-49.
Children receiving 40 sessions of theta-suppression / beta-enhancement neurofeedback showed significant gains in IQ (mean +9 points) and reductions in inattentive behaviour versus waitlist controls. An early RCT supporting clinical efficacy. DOI: 10.1007/BF02214148 | PMID 8833315
Monastra et al., 2002 – neurofeedback alongside stimulants and parenting
Applied Psychophysiology & Biofeedback, 27(4): 231-249.
One-year study comparing Ritalin alone vs Ritalin + EEG neurofeedback + parenting. Both arms improved on stimulants, but only the neurofeedback group sustained gains in attention, behaviour, and academic performance after medication washout – direct evidence of durable, drug-independent change. DOI: 10.1023/A:1021018700609 | PMID 12557451
Levesque, Beauregard & Mensour, 2006 – neurofeedback changes the ADHD brain
Neuroscience Letters, 394(3): 216-221.
Children with ADHD completed 40 neurofeedback sessions. Post-training fMRI showed normalization of activation in the anterior cingulate cortex during selective-attention tasks, paralleling significant clinical improvement. Biological proof that neurofeedback drives measurable neural change. DOI: 10.1016/j.neulet.2005.10.100 | PMID 16343769
Arns et al., 2009 – meta-analysis of neurofeedback efficacy in ADHD
Clinical EEG and Neuroscience, 40(3): 180-189.
Meta-analysis covering 15 studies and 1,194 ADHD patients. Large effect sizes for inattention (0.81) and impulsivity (0.69), with a medium effect for hyperactivity (0.40). The authors concluded neurofeedback meets criteria for an “efficacious and specific” treatment. DOI: 10.1177/155005940904000311 | PMID 19715181
Gevensleben et al., 2009 – randomized controlled trial vs attention-training control
Journal of Child Psychology and Psychiatry, 50(7): 780-789.
102 children randomized to 36 sessions of neurofeedback or computerized attention training. The neurofeedback arm produced significantly greater improvements on the FBB-HKS ADHD scale, replicated across both clinician and parent ratings. DOI: 10.1111/j.1469-7610.2008.02033.x | PMID 19207632
Recent Randomized Trials and Meta-Analyses
Modern studies continue to support and extend the foundational findings, with longer follow-ups and refined protocols.
Van Doren et al., 2019 – sustained-effects meta-analysis
European Child & Adolescent Psychiatry, 28(3): 293-305.
10 follow-up studies in children. Within-group neurofeedback effects on inattention grew from SMD 0.64 immediately post-treatment to SMD 0.80 at 2-12 month follow-up – benefits actually strengthened over time. One of the strongest arguments for neurofeedback as a durable, learning-based intervention. DOI: 10.1007/s00787-018-1121-4 | PMID 29445867
Riesco-Matias et al., 2021 – updated meta-analysis of meta-analyses
Journal of Attention Disorders, 25(4): 473-485.
17 RCTs in children plus a synthesis of 7 prior meta-analyses confirms significant benefit on inattention, particularly with standard protocols and adequate session count. DOI: 10.1177/1087054718821731 | PMID 30646779
Westwood et al., 2025 – JAMA Psychiatry meta-analysis
JAMA Psychiatry, 82(2): 118-129.
The most current rigorous meta-analysis, covering 38 RCTs and 2,472 participants. Standard EEG protocols (theta/beta, SCP, SMR) produced significant improvements on ADHD symptoms (SMD 0.21) and processing speed (SMD 0.35), confirming that protocol selection and session count matter for outcomes. DOI: 10.1001/jamapsychiatry.2024.3702 | PMID 39661381
Why Neurofeedback Often Appeals to Families
- Non-pharmacological. No stimulant side effects, no rebound, no daily dosing.
- Skill-based. What the brain learns is yours – benefits commonly persist long after training ends.
- Excellent tolerability. The vast majority of trials report no serious adverse events.
- Compatible with medication. Many families combine NF with stimulants and reduce dose over time.
- Backed by ISNR and AAP. Both bodies recognize biofeedback as an evidence-supported ADHD intervention.
A Few Honest Caveats
- Not every protocol works for every child. Quality of clinician training and protocol selection matter a lot.
- Standard protocols typically need 30-40 sessions over 3-6 months for full benefit.
- Neurofeedback complements rather than replaces stimulant medication on average; for many families it lets them taper or skip medication.
- Blinded-rater meta-analyses show smaller group effects than parent-rated ones – a long-running methodological debate in the field.
Is Neurofeedback Right for Your ADHD?
For families who want a non-pharmacological, skill-based approach – either as a first step, alongside medication, or to support tapering – EEG neurofeedback has the longest research track record of any complementary intervention for ADHD. Most patients see meaningful change within 30-40 sessions, and follow-up data suggest the gains often grow after training ends.
Want to Dig Deeper Into the Research?
The International Society for Neuroregulation & Research (ISNR) maintains the comprehensive bibliography of peer-reviewed neurofeedback studies across conditions.
Last reviewed: April 2026. This page is for general information and does not constitute medical advice. Always speak with a qualified clinician about your treatment options.